Valuation Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 07:30:00 05/06/2026 BST			5-day change	1st Jan Change
4,926.00 ^JPY	+1.57%		-3.75%	+1.88%

06-05	Takeda Books $2.5 Billion Provision Related to Amitiza Antitrust Litigation	DJ
06-02	FDA declines to approve Cingulate's ADHD treatment over manufacturing issues	RE

Company Valuation: Takeda Pharmaceutical Company Limited

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	6,229,971	5,423,454	6,762,204	6,564,378	6,749,675	7,782,280	-	-
Change	-	-12.95%	24.68%	-2.93%	2.82%	15.3%	-	-
Enterprise Value (EV) ¹	9,862,522	8,919,170	10,611,015	10,950,330	10,725,175	5,130,461	11,664,032	11,469,778
Change	-	-9.57%	18.97%	3.2%	-2.06%	-52.16%	-0.49%	-1.67%
P/E ratio	16.6x	23.8x	21.3x	45.4x	64.6x	46.4x	35.7x	25.5x
PBR	1.2x	0.95x	1.06x	0.9x	1x	1.15x	1.07x	1.07x
PEG	-	-0.6x	0.5x	-0.8x	-2.5x	0.6x	1.6x	0.6x
Capitalization / Revenue	1.95x	1.52x	1.68x	1.54x	1.47x	1.99x	1.68x	1.66x
EV / Revenue	3.08x	2.5x	2.63x	2.57x	2.34x	1.14x	2.53x	2.44x
EV / EBITDA	9.23x	8.54x	9.19x	11.6x	9.71x	4.54x	9.15x	8.31x
EV / EBIT	19.4x	19.4x	21.6x	51.1x	31.3x	12.6x	23.7x	18.9x
EV / FCF	16x	8.92x	28.7x	43.4x	15.5x	8.14x	14x	15.5x
FCF Yield	6.26%	11.2%	3.49%	2.31%	6.43%	12.3%	7.16%	6.46%
Dividend per Share ²	180	180	180	188	196	200	204.8	208.5
Rate of return	4.52%	5.15%	4.14%	4.49%	4.44%	3.53%	4.16%	4.23%
EPS ²	240.7	147.1	204.3	92.09	68.36	122	138.1	193
Distribution rate	74.8%	122%	88.1%	204%	287%	164%	148%	108%
Net sales ¹	3,197,812	3,569,006	4,027,478	4,263,762	4,581,600	4,505,700	4,618,997	4,693,583
EBITDA ¹	1,068,940	1,043,995	1,154,905	942,077	1,103,982	1,129,888	1,275,055	1,379,935
EBIT ¹	509,269	460,844	490,505	214,100	342,600	408,800	491,410	605,757
Net income ¹	376,005	230,059	317,017	144,067	107,900	191,800	207,131	311,980
Net Debt ¹	3,632,551	3,495,716	3,848,811	4,385,952	3,975,500	-3,817,600	3,881,752	3,687,499
Reference price ²	3,985.00	3,498.00	4,350.00	4,184.00	4,413.00	4,926.00	4,926.00	4,926.00
Nbr of stocks (in thousands)	1,563,355	1,550,444	1,554,530	1,568,924	1,529,498	1,579,838	-	-
Announcement Date	11/05/21	11/05/22	11/05/23	09/05/24	08/05/25	13/05/26	-	-

¹JPY in Million²JPY

Estimates

P/E ratio, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
TAKEDA PHARMACEUTICAL COMPANY LIMITED	43.84x	2.59x	9.55x	4.06%	48.56B
ELI LILLY AND COMPANY	33.11x	12.04x	24.78x	0.6%	1,009B
JOHNSON & JOHNSON	24.88x	5.74x	15.6x	2.29%	560B
ABBVIE INC.	27.82x	6.77x	13.84x	3.02%	401B
ROCHE HOLDING AG	17.55x	4.34x	10.65x	3.07%	328B
ASTRAZENECA PLC	23.42x	4.85x	13.81x	1.8%	288B
NOVARTIS AG	20.62x	5.32x	12.95x	3.06%	272B
NOVO NORDISK A/S	12.56x	4.71x	9.62x	4%	194B
AMGEN INC.	22.73x	6.08x	10.62x	2.89%	189B
GILEAD SCIENCES, INC.	-46.22x	5.58x	31.48x	2.51%	160B
Average	18.03x	5.80x	15.29x	2.73%	345.02B
Weighted average by Cap.	22.62x	7.37x	17.29x	2.14%